NCT04699383View on ClinicalTrials.gov

Documentation of Patient Outcomes for SSG/Allopurinol Combination Treatment in Ethiopia

CompletedOBSERVATIONAL
Enrollment

105

Participants

Timeline

Start Date

February 15, 2021

Primary Completion Date

December 15, 2022

Study Completion Date

December 15, 2022

Conditions
Cutaneous Leishmaniasis
Interventions
DRUG

Sodium Stibogluconate with allopurinol

Routine administration of SSG/allopurinol combination treatment, from 1-5 cycles

Trial Locations (1)

Unknown

Boru Meda Hospital, Dessie

All Listed Sponsors
collaborator

Wollo University

OTHER

collaborator

Boru Meda Hospital

UNKNOWN

collaborator

University of Gondar

OTHER

lead

Institute of Tropical Medicine, Belgium

OTHER

NCT04699383 - Documentation of Patient Outcomes for SSG/Allopurinol Combination Treatment in Ethiopia | Biotech Hunter | Biotech Hunter